Accelerating Early-Stage Oncology Global Drug Development: Connecting West to East, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn how early-stage oncology programs can integrate Western and Asian markets into a global development strategy. The featured speakers will discuss regulatory pathways, site selection, investigator networks and patient access across North America, Europe and Asia-Pacific. Attendees will also explore how early clinical, regulatory and operational planning can reduce development risk and support faster progress toward key oncology milestones.

TORONTO, Nov. 4, 2026 /PRNewswire/ -- Early-stage oncology development is increasingly global. For emerging biopharma, the goal is not simply to expand into more countries, but to build a development strategy that identifies the right markets, regulatory pathways, sites, investigators and patient populations from the outset.

This webinar brings together oncology drug development experts from Allucent and CMIC to examine how sponsors can strategically incorporate key Western and Asian markets into early-stage oncology programs. The speakers will explore how local expertise and site networks can help sponsors navigate differences between markets and determine where and when each market fits within a global development strategy.

Allucent will examine early oncology development across the US, EU and Canada, including how integrated product development, regulatory, clinical and operational planning can inform critical early decisions and strengthen the path to later-stage development. The discussion will also consider how strategic site selection and established site relationships, including Allucent's IGNITE Site Network, can support faster study start-up, access to oncology expertise and patient populations and more predictable enrolment.

CMIC will provide an Asia-Pacific perspective, focusing on South Korea and Taiwan and how these markets can contribute to global oncology programs. The discussion will examine regulatory pathways, clinical trial infrastructure, access to leading cancer centers and experienced investigators and practical considerations for site identification, activation and patient recruitment.

Together, Allucent and CMIC will provide a practical view of how product development strategy, regulatory planning, operational expertise and site and patient access can be aligned across North America, Europe and Asia-Pacific. For small and mid-size biopharma, this integrated approach can help focus resources, reduce development risk and accelerate the path to critical oncology milestones.

Register for this webinar to learn how a globally integrated oncology drug development strategy can reduce risk and accelerate progress toward critical development milestones.

Join Shinichi Nagase, Senior Director, CRO & Consulting Unit, CMIC Holdings Co. Ltd.; and Ray Reilly, Senior Vice President, Global Clinical Operations, Allucent, for the live webinar on Thursday, November 19, 2026, at 11am EST (5pm CET / EU-Central).

For more information, or to register for this event, visit Accelerating Early-Stage Oncology Global Drug Development: Connecting West to East.

ABOUT XTALKS

Xtalks – The Life Science Community™ empowers professionals across pharma, biotech, medtech, healthcare and research with the trusted knowledge and collaborative insights that move the industry forward. Powered by Honeycomb Worldwide Inc., Xtalks delivers news, feature articles, webinars, podcasts, videos, expert interviews, curated job opportunities and more designed to support informed decision-making in a fast-evolving sector.

Every year, thousands of professionals rely on Xtalks for timely intelligence, peer perspectives and industry thought leadership. Join our life science community to stay informed, connected and ready for what's next.

To learn more about Xtalks, visit www.xtalks.com
For information about working with Xtalks to host your webinar, visit https://xtalks.com/partner-with-us/

Contact:
Soumya Shashikumar
Tel: +1 (416) 977-6555 x371
Email: skumar@xtalks.com

SOURCE Xtalks